Metabolic volumetric parameters versus Deauville scoring for therapy response in multiple myeloma patients. | ||||
| Egyptian Journal Nuclear Medicine | ||||
| Volume 29, Issue 2, December 2024, Page 40-47 PDF (203.32 K) | ||||
| Document Type: Original Paper, PET/CT | ||||
| DOI: 10.21608/egyjnm.2024.325598.1106 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Maha Mehesen  1; Hosna Moustafa2; Aya Ashraf3; huda fathy4; Ehab Mosaad Abdelghany5; Salwa Abd El-Gaid6
| ||||
| 1nuclear medicine, national cancer institute, Cairo, Egypt | ||||
| 2Oncology and Nuclear Medicine Department, Kasr Al-Aini Hospital, Cairo University, Egypt. | ||||
| 3Nuclear medicine unit, National Cancer Institute, Cairo University. | ||||
| 4nuclear medicine department, National Cancer Institute, Cairo University, Cairo, Egypt. | ||||
| 5Medical Oncology Department, National Cancer Institute, Cairo University. | ||||
| 6Nuclear Medicine Unit, National Cancer Institute (NCI) Cairo University, Cairo, Egypt. | ||||
| Abstract | ||||
| Background: 18F-FDG PET/CT is an efficient modality to monitor minimal residual disease (MRD), detect extra-medullary disease, assess disease burden, and therapy response in multiple myeloma patients. Purpose: The aim of this study is to assess therapy response in MM patients using both Deauville scoring (DS) and metabolic volumetric parameters and detect their predictive value. Patients and methods: A total of 50 adult patients newly diagnosed with multiple myeloma (MM) were prospectively evaluated. Using DS and metabolic parameters for analysis of initial and interim FDG-PET/CT scans , and then their prognostic value was detected. Results: No statistical significance was detected for DS either in initial or interim PET/CT studies. Regarding the metabolic parameters, initial metabolic tumor volume (MTV) and TLG between responder and non-responder categories showed notable significance with a p value of 0.004. Moreover, interim MTV, total lesion glycolysis (TLG) and SUVpeak determined p values of 0.021, 0.009, and 0.007, respectively. Conclusion: Metabolic volumetric parameters were promising tools to predict outcome in MM patients. The cutoff of initial MTV greater than 70 showed sensitivity of 78 % and specificity of 71.4%. The sensitivity of 56% and specificity of 93% for the cutoff of initial TLG more than 350. Interim SUVpeak level with a cutoff point of more than 3, showing sensitivity of 86% and specificity of 73%. | ||||
| Keywords | ||||
| Metabolic volumetric parameters; Deauville scoring; therapy response; multiple myeloma patients | ||||
|
Statistics Article View: 93 PDF Download: 77 |
||||
